Expanding antiretroviral therapy in Malawi: drawing on the country's experience with tuberculosis
- 11 November 2004
- Vol. 329 (7475) , 1163-1166
- https://doi.org/10.1136/bmj.329.7475.1163
Abstract
The DOTS (“directly observed treatment, short course”) strategy has been successfully used in developing countries to provide effective control of tuberculosis. Field workers in Malawi are promoting the same approach for HIV infection through the expansion of highly active antiretroviral therapyKeywords
This publication has 10 references indexed in Scilit:
- Antiretroviral therapy in AfricaBMJ, 2004
- Global health improvement and WHO: shaping the futureThe Lancet, 2003
- Decline in the AIDS and death rates in the EuroSIDA study: an observational studyThe Lancet, 2003
- Doubts about DOT: antiretroviral therapy for resource-poor countriesAIDS, 2003
- Directly Observed Therapy for the Treatment of People with Human Immunodeficiency Virus Infection: A Work in ProgressClinical Infectious Diseases, 2002
- Can guardians supervise TB treatment as well as health workers? A study on adherence during the intensive phase.2001
- Preventing antiretroviral anarchy in sub-Saharan AfricaThe Lancet, 2001
- Trends in antituberculosis drug resistance in Karonga District, Malawi, 1986-1998.2000
- Evaluation of a unified treatment regimen for all new cases of tuberculosis using guardian-based supervision.2000
- Declining Morbidity and Mortality among Patients with Advanced Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1998